BELLUS Health Inc.
BLU was delisted on the 28th of June, 2023.
1 hedge funds and large institutions have $649 invested in BELLUS Health Inc. in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 11 closing their positions.
91% less funds holding
Funds holding: 11 → 1 (-10)
91% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 11
100% less capital invested
Capital invested by funds: $6.71M → $649 (-$6.71M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAS
Coppell Advisory Solutions
Coppell,
Texas
|
+$649 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Carmignac Gestion
Paris,
France
|
-$3.26M |
| 2 |
VAM
Vazirani Asset Management
New York
|
-$1.62M |
| 3 |
Barclays
London,
United Kingdom
|
-$1.13M |
| 4 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
-$217K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$172K |
BLU Hedge Fund Activity: Q3 2023 in Review
1 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q3 2023, worth a combined $649 — down 100% from $6.71M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of BLU and 1 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Coppell Advisory Solutions, opening a new position worth an estimated $649. The largest seller was Carmignac Gestion, exiting entirely with an estimated $3.26M sold.
- 1 institutional investor held BELLUS Health Inc. (BLU) as of Q3 2023, down from 11 in Q2 2023.
- Funds reported $649 of BELLUS Health Inc. stock for Q3 2023, down 100% quarter-over-quarter.
- 1 fund opened new BELLUS Health Inc. positions in Q3 2023 and 11 closed out, a net change of -10 holders.
- The largest BELLUS Health Inc. buyer in Q3 2023 was Coppell Advisory Solutions, an estimated $649 added.
- The largest BELLUS Health Inc. seller in Q3 2023 was Carmignac Gestion, an estimated $3.26M sold.
Based on aggregated 13F filings for Q3 2023.